Histone H1 suppresses tumor growth of leukemia cells in vitro, ex vivo and in an animal model suggesting extracellular functions of histones

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 19, Issue 5, 1996, Pages 522-531

  Class, Reiner ^a,b   Lindman, Sissel ^c   Fassbender, Cordula ^a   Leinenbach, Hans Peter ^a   Rawer, Stefan ^a   Emrich, Jacqueline G ^b   Brady, Luther W ^b   Zeppezauer, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Cell cycle; Cell surface proteins; Cytoskeleton; Thymic proteins

Indexed keywords

CELL SURFACE PROTEIN; HISTONE H1; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; DOSE TIME EFFECT RELATION; GROWTH INHIBITION; LEUKEMIA; LEUKEMIA CELL; LYMPHOMA CELL; NONHUMAN; NUDE MOUSE; PROTEIN PURIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; BURKITT LYMPHOMA; CELL MEMBRANE; FEMALE; HISTONES; LEUKEMIA, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED;

EID: 0029842987     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199610000-00019     Document Type: Article

References (44)

1. Elgin SCR Weintraub H. Chromosomal proteins and chromatin structure. Ann Rev Biochem 1975;44:725-74.
2. Grunstein M. Histones as regulators of genes. Sci Am 1992;267:68-74B.
3. Eberhardt NL, Ring JC, Johnson LK, Latham KR, Apriletti JW, Kitsis RN, Baxter JD. Regulation of activity of chromatin receptors for thyroid hormone: possible involvement of histone-like proteins. Proc Natl Acad Sci 1979;76:5005-9.
4. Minota S, Miura H, Misaki Y, Yamamoto K, Morino N, Sarkurai H, Yamada A, Razaki Y. Relationship between autoepitope and DNA-binding site on a histone H1 molecule. Autoimmunity 1992;13:261-4.
5. Leak AM, Woo P. Juvenile chronic arthritis, chronic iridocyclitis, and reactivity to histones. Ann Rheum Dis 1991;50:653-7.
6. Wesierska-Gadek J, Penner E, Lindner H, Hitchman E, Sauermann G. Autoantibodies against different histone H1 subtypes in systemic lupus erythematosus sera. Arthritis Rheun 1990;33:1273-8.
7. Krippner H, Springer B, Merle S, Pirlet K. Antibodies to histones of the IgG and IgM class in systemic lupus erythematosus. Clin Exp Immunol 1994;58:49-56.
8. Raska I, Petrasovicova V, Jarnik M, et al. Autoantibodies against histones and actin determined by western blotting in patients with rheumatic diseases. Ustav Exp Med 1990;129:1495-500.
9. Dohlman JG, Pillion DJ, Rokeach LA, Ramprasad MP. Identification of macrophage cell-surface binding sites for cationized bovine serum albumin. Biochem Biophys Res Commun 1991;181:787-96.
10. Bell DA, Morrison B, VandenBygaart P. Immunologic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J Clin Invest 1990;85:1487-96.
11. Multigner L, Gagnon J, Van Dorsselaer A, Job D. Stabilization of sea urchin flagellar microtubules by histone h1. Nature 1992;360:33-9.
12. Sorace JM, Johnson RJ. A cytotoxic monoclonal anti-leukemia antibody binds to histone H1. Hybridoma 1990;9:419-27.
13. Pereira LF, Marco FM, Boimorto R, et al. Histones interact with anionic phospholipids with high avidity; its relevance for the binding of histone-antihistone immune complexes. Clin Exp Immunol 1994;97:175-80.
14. Holers VM, Kotzin BL. Human peripheral blood monocytes display surface antigens recognized by monoclonal antinuclear antibodies. J Clin Invest 1985;76:991-8.
15. Miller BJ, Pauls JD, Fritzler MJ. Human monoclonal antibodies demonstrate polyreactivity for histones and the cytoskeleton. J Autoimmun 1991;4:665-79.
16. Comsa J, Leonhardt H, Weckerly H. Hormonal coordination of the immune response [review]. Rev Physiol Biochem Pharmacol 1982;92:116-91.
17. Zeppezauer M, Reichhart R. Use of histone H1 and H2A:H2B dimers in therapeutic methods. 1989. US Patent 5,182,257.
18. Reichhart R. Jörnvall H, Carlquiest M, Zeppezauer M. The primary structure of two polypeptide chains from preparations of the homeostatic thymus hormone. FEBS Lett 1985;188:63-7.
19. Reichhart R, Zeppezauer M, Jörnvall H. Preparations of the homeostatic thymus hormone consist predominantly of histones 2a and 2b and suggest additional histone functions. Proc Natl Acad Sci USA 1985;82:4871-5.
20. Cebecauer L, Zeppezauer M, Lukacovicova L, et al. Immunologic activities of histones. Rheumatologia 1991;5:107-15.
21. Comsa J, Baumann B, Zeppezauer M, Leonhardt H, Weber N. Influence of the homeostatic thymus hormone on radioleucosis in mice. Comptes Rendus Des Seances De L'Academic Des Sciences-Serie D, Sciences Naturelles 1991;288:185-7.
22. Leinebach HP. [Dissertation] Saarbrücken, Germany: University of Saarland, 1990.
23. Lindman S, Leinenbach HP, Korsgaard R, Class R, Hollemeyer K, Reichhart R, Zeppezauer M. Growth inhibition of human lymphatic cancer cells by the homeostatic thymic hormone in vitro. Medical Science Research 1991;19:27-28.
24. Class R. [Dissertation] Saarbrücken, Germany: University of Saarland, 1991.
25. Morgan D. Differential cytokine response of human lineage specific progenitor cell lines. Blood 1993;82:373a.
26. Morgan D, Soslau G, Brodsky I. Differential effects of thrombopoetin (mpl) on cell lines MB-02 and HU-3 derived from patients with megacaryoblastic leukemia. Blood 1994;84:330a.
27. Abrams JT, Lessin S, Ghosh SK, et al. A clonal CD4-positive T-cell line established from the blood of a patient with Sézary syndrome. J Invest Dermatol 1991;96:31-7.
28. Pehrson JR, Cole RD, Histone H1 subfractions and H1O turnover at different rates in nondividing cells. Biochemistry 1981;20:2298-2301.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983;65:55-63.
30. Pagé B, Pagé M, Noël C. A new fluorimetric assay for cytotoxicity measurements in vitro. International Journal of Oncology 1993;3:473-6.
31. Aeschbacher M, Reinhardt CA, Zbinden G. A rapid cell membrane permeability test using fluorescent dyes and flow cytometry. Cell Biol Toxicol 1987;2:247-55.
32. Yuhas IM, Li AP, Martinez AO, Ladmanm A. A simplified method for production and growth of multicellular tumor spheroids. J Cancer Res 1977;37:3639-3643.
33. Hoffmann R. [Dissertation] Saarbrücken, Germany: University of Saarland, 1993.
34. Comsa J. Hormonal interactions of the thymus. In: Luckey TT, ed. Thymic hormones. Baltimore: University Press, 1973:39-58.
35. Comsa J. Hormonal interactions of the thymus. In: Luckey TT, ed. Thymic hormones. Baltimore: University Press, 1973:59-96.
36. Waga S, Tan EM, Rubin RL. Identification and isolation of soluble histones from bovine milk and serum. Biochem J 1987;244:675-82.
37. Goya RG, Sosa YE, Quickley KL, Reichhart R, Meites J. Homeostatic thymus hormone stimulates corticosterone secretion in a dose- and age-dependent manner in rats. Neuroencocrinology 1990;51:59-63.
38. Goya RG, Castro MG, Linton EA, Woods RJ, Sosa YE, Lowry PJ. Histones and related preparations interfere with immunoassays for peptide hormones. Peptides 1993;14:777-81.
39. Watson K, Edwards RJ, Shaunak S, Parmelee DC, Sarraf C, Gooderman NJ, Davies DS. Extra-nuclear location of histones in activated human peripheral blood lymphocytes and cultured T-cells. Biochem Pharmacol 1995;50:299-309.
40. Cohen J, Bakimer R, Blank M, Valesini G, Shoenfeld Y. Pathogenic natural anti-cardiolipin antibodies: the experience from monoclonal gammopathy. Clin Exp Immunol 1994;97:181-6.
41. Pettersson T, Pukkala E, Teppo L, Friman C. Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis 1992;51:437-9.
42. Thompson C. Protein proves to be a key link in innate immunity. Science 1995;269:301-2.
43. Summerfield JA, Ryder S, Sumiya M, Thursz M, Gorchein A, Monteil MA, Turner MW. Mannose binding protein gene mutations associated with usnusual and severe infections in adults. Lancet 1995;345:886-9.
44. Sumiya M, Super M, Tabona P, Levinsk RJ, Arai T, Turner MW, Summerfield JA. Molecular basis of opsonic defect in immunodeftcient children. Lancet 1991;337:1569-70.